DexCom (DXCM) Metrics: History & Chart

DexCom, Inc.(DXCM)

Medical - Devices · San Diego, CA

$84.51+0.63 (+0.75%)

Delayed quote: Sep 10, 2026, 4:00 PM EDT

About DexCom, Inc.

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.

San Diego, CA

11,050 employees

www.dexcom.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Jacob Steven Leach

View full financials

Third-Party DCF Estimate (FMP)	$44.54
Price Gap vs Third-Party Estimate	-47.29%

7D Total Return	-5.80%
30D Total Return	-5.61%
YTD Total Return	+27.33%
1Y Total Return	+11.20%
3Y Total Return	-18.97%
5Y Total Return	-38.48%
10Y Total Return	+263.63%
15Y Total Return	+2800.71%
20Y Total Return	+2850.99%

2026	+27.33%
2025	-14.66%
2024	-37.33%
2023	+9.58%
2022	-15.64%
2021	+45.23%
2020

CAGR TTM	+11.21%
CAGR 3Y	-6.77%
CAGR 5Y	-9.26%
CAGR 10Y	+13.78%
CAGR 15Y	+25.17%
CAGR 20Y	+18.44%

PE Ratio	33.40
PE Ratio Avg TTM	34.46
PE Ratio Avg 3Y	57.36
Current VS TTM Avg	-3.08%
Current VS 3Y Avg	-41.77%
Current VS 5Y Avg	-68.75%

All Metrics

DXCM Valuation Metrics

DXCM Stock Price Metrics

DXCM Dividend Metrics

DXCM Growth Rate Metrics

DXCM Discounted Cash Flow Metrics

DXCM Returns By Period

DXCM Yearly Returns

DXCM Average Annual Returns By Period (CAGR)

DXCM Revenue Metrics

DXCM PE Ratio Metrics

DXCM PS Ratio Metrics

DXCM PB Ratio Metrics

DXCM Price to Free Cash Flow Ratio Metrics

DXCM Debt to Equity Ratio Metrics

DXCM PEG Ratio Metrics

DXCM FCF Yield

DXCM Earnings Yield

DXCM EBITDA Yield

DXCM OCF Yield

DXCM EV/EBIT Ratio Metrics

DXCM EV/EBITDA Ratio Metrics

DXCM EV/Assets Ratio Metrics

DXCM EV/Sales Ratio Metrics

DXCM Current Ratio Metrics

DXCM Quick Ratio Metrics

DXCM ROIC Metrics

DXCM Return on Assets Metrics

DXCM Return on Equity Metrics

DXCM Net Profit Margin Metrics

DXCM Gross Profit Margin Metrics

DXCM Tax Rate Metrics

PS Ratio	6.66
PS Ratio Avg TTM	6.06
PS Ratio Avg 3Y	8.98
Current VS TTM Avg	+9.99%
Current VS 3Y Avg	-25.84%
Current VS 5Y Avg	-46.84%

PB Ratio	12.63
PB Ratio Avg TTM	9.95
PB Ratio Avg 3Y	15.28
Current VS TTM Avg	+26.98%
Current VS 3Y Avg	-17.36%
Current VS 5Y Avg	-30.64%

PFCF Ratio	23.57
PFCF Ratio Avg TTM	23.34
PFCF Ratio Avg 3Y	56.27
Current VS TTM Avg	+0.98%
Current VS 3Y Avg	-58.11%
Current VS 5Y Avg	-76.02%

Debt/Equity Ratio	0.53
Debt/Equity Ratio Avg TTM	0.69
Debt/Equity Ratio Avg 3Y	1.13
Current VS TTM Avg	-22.80%
Current VS 3Y Avg	-52.82%
Current VS 5Y Avg	-50.29%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	4.24%
FCF Yield Avg TTM	4.33%
FCF Yield Avg 3Y	2.38%
Current VS TTM Avg	-2.05%
Current VS 3Y Avg	+78.04%
Current VS 5Y Avg	+202.46%

Earnings Yield	2.99%
Earnings Yield Avg TTM	2.89%
Earnings Yield Avg 3Y	2.00%
Current VS TTM Avg	+3.29%
Current VS 3Y Avg	+49.57%
Current VS 5Y Avg	+108.15%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	29.33
Ev/Ebit Ratio Avg TTM	32.77
Ev/Ebit Ratio Avg 3Y	57.35
Current VS TTM Avg	-10.49%
Current VS 3Y Avg	-48.86%
Current VS 5Y Avg	-69.34%

Ev/Ebitda Ratio	23.81
Ev/Ebitda Ratio Avg TTM	25.40
Ev/Ebitda Ratio Avg 3Y	43.32
Current VS TTM Avg	-6.28%
Current VS 3Y Avg	-45.04%
Current VS 5Y Avg	-65.70%

Ev/Assets Ratio	5.17
Ev/Assets Ratio Avg TTM	4.07
Ev/Assets Ratio Avg 3Y	5.46
Current VS TTM Avg	+26.89%
Current VS 3Y Avg	-5.30%
Current VS 5Y Avg	-27.53%

Ev/Sales Ratio	6.72
Ev/Sales Ratio Avg TTM	6.19
Ev/Sales Ratio Avg 3Y	9.36
Current VS TTM Avg	+8.53%
Current VS 3Y Avg	-28.17%
Current VS 5Y Avg	-48.28%

Current Ratio	1.73
Current Ratio Avg TTM	1.73
Current Ratio Avg 3Y	2.14
Current VS TTM Avg	+0.21%
Current VS 3Y Avg	-19.08%
Current VS 5Y Avg	-40.81%

Quick Ratio	1.43
Quick Ratio Avg TTM	1.48
Quick Ratio Avg 3Y	1.87
Current VS TTM Avg	-3.46%
Current VS 3Y Avg	-23.81%
Current VS 5Y Avg	-45.43%

ROIC	21.71%
ROIC Avg 3Y	10.28%
ROIC Avg 5Y	8.87%
Current VS 3Y Avg	+111.19%
Current VS 5Y Avg	+144.90%
Current VS 10Y Avg	+602.09%

ROA	15.49%
ROA Avg TTM	11.04%
ROA Avg 3Y	9.26%
Current VS TTM Avg	+40.31%
Current VS 3Y Avg	+67.23%
Current VS 5Y Avg	+75.52%

ROE	38.14%
ROE Avg TTM	29.74%
ROE Avg 3Y	26.91%
Current VS TTM Avg	+28.24%
Current VS 3Y Avg	+41.75%
Current VS 5Y Avg	+70.80%

Net Profit Margin	20.12%
Net Profit Margin Avg TTM	19.20%
Net Profit Margin Avg 3Y	16.46%
Current VS TTM Avg	+4.79%
Current VS 3Y Avg	+22.23%
Current VS 5Y Avg	+50.30%

Gross Profit Margin	62.47%
Gross Pft Margin Avg TTM	61.87%
Gross Pft Margin Avg 3Y	61.41%
Current VS TTM Avg	+0.98%
Current VS 3Y Avg	+1.73%
Current VS 5Y Avg	-0.50%

Tax Rate	21.54%
Tax Rate Avg 3Y	24.88%
Tax Rate Avg 5Y	25.55%
Current VS 3Y Avg	-13.41%
Current VS 5Y Avg	-15.68%
Current VS 10Y Avg	+23.25%